HOME
PRODUCT
SOLUTION
SUPPORT
ABOUT
CONTACT
Approximately 300 million eligible women aged 35 to 64 in China need to undergo cervical cancer screening.
In the realm of medical diagnostics, understanding EBER Probe testing is crucial. The identification of latent Epstein-Barr virus (EBV) infections relies heavily on this approach, which detects EBV in tissue samples.
Molecular diagnosis is an important part of modern medicine because it uses genetic and molecular markers to correctly identify illnesses.
Molecular diagnostics play a pivotal role in modern healthcare, revolutionizing disease detection and treatment strategies.
Thyroglobulin antibody serves as a crucial marker for autoimmune thyroid disease, the primary cause of hypothyroidism and hyperthyroidism in the United States.
Bladder cancer remains a significant health concern worldwide, with a substantial impact on both men and women. Accurate diagnosis and effective management are critical for improving patient outcomes. In this blog, we explore the vital role of immunohistochemistry (IHC) biomarkers in bladder cancer, highlighting both established and emerging markers that are shaping the future of cancer diagnostics and treatment.
Antibodies, also known as immunoglobulins, are essential proteins produced by the immune system to defend the body against harmful invaders. These microscopic defenders play a crucial role in identifying and neutralizing foreign substances such as bacteria and viruses. There are five main types of antibodies, each with specific functions: IgG, IgM, IgA, IgD, and IgE.
Molecular diagnostics is a cutting-edge field that plays a pivotal role in modern medicine. It involves analyzing DNA and RNA to uncover valuable insights into genetic information, diseases, and personalized treatments. The global molecular diagnostics market has experienced substantial growth, with a projected value of USD 61.29 billion by 2033 at a CAGR of 3.8% from 2024 to 2033.